Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
B 127.12 0.43% 0.55
ABT closed down 1.24 percent on Tuesday, January 18, 2022, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Jan 25
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical ABT trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.33%
Lower Bollinger Band Walk Weakness 0.33%
Strong but Oversold Other 0.33%
Below Lower BB Weakness 0.33%
Down 3 Days in a Row Weakness 0.33%
Down 4 Days in a Row Weakness 0.33%
Oversold Stochastic Weakness 0.33%
MACD Bearish Centerline Cross Bearish -0.91%
Multiple of Ten Bearish Other -0.91%
Below Lower BB Weakness -0.91%
Older End-of-Day Signals for ABT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Abbott Laboratories Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: S&P 500 Medicine Cancer Life Sciences Infectious Diseases Pain Eye Diabetes Pharmaceutical Products Inflammation Hypertension Influenza Hematology Lab Testing Spas Lipid Thyroid Glucose Vascular Disease Diagnostic Products Fertility Health Care Products Immunoassay Nutritional Products Blood Glucose Monitoring Cataracts Fever Generic Pharmaceutical Influenza Vaccine Contact Lens Dyslipidemia Irritable Bowel Syndrome Vascular Products Cataract Surgery Data Management Software Generic Pharmaceuticals Lasik Diagnostic Systems Cholestasis Hypothyroidism Infectious Agents Intrahepatic Cholestasis Lake Bluff Lens Care Products

Is ABT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 142.51
52 Week Low 105.36
Average Volume 5,378,462
200-Day Moving Average 123.14
50-Day Moving Average 132.18
20-Day Moving Average 136.15
10-Day Moving Average 133.07
Average True Range 2.69
ADX 25.45
+DI 12.90
-DI 36.81
Chandelier Exit (Long, 3 ATRs) 134.44
Chandelier Exit (Short, 3 ATRs) 133.62
Upper Bollinger Bands 144.54
Lower Bollinger Band 127.76
Percent B (%b) -0.07
BandWidth 12.32
MACD Line -0.93
MACD Signal Line 0.67
MACD Histogram -1.5952
Fundamentals Value
Market Cap 224.33 Billion
Num Shares 1.77 Billion
EPS 1.89
Price-to-Earnings (P/E) Ratio 66.93
Price-to-Sales 5.95
Price-to-Book 6.07
PEG Ratio 3.38
Dividend 1.44
Dividend Yield 1.14%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 129.84
Resistance 3 (R3) 129.86 128.80 129.30
Resistance 2 (R2) 128.80 127.96 128.79 129.11
Resistance 1 (R1) 127.68 127.45 127.15 127.66 128.93
Pivot Point 126.62 126.62 126.35 126.61 126.62
Support 1 (S1) 125.50 125.78 124.97 125.48 124.21
Support 2 (S2) 124.44 125.27 124.43 124.03
Support 3 (S3) 123.32 124.44 123.85
Support 4 (S4) 123.30